← Back to VOLUME 12, ISSUE 6, JUNE 2025
This work is licensed under a Creative Commons Attribution 4.0 International License.
SWISSADME PREDICTIONS OF PHARMACOKINETICS AND DRUG-LIKENESS PROPERTIES OF 5-FLUOROURACIL (5FU)
👁 1 view📥 0 downloads
Abstract: Swiss ADME web tool is empolyed for study of Absorption, Distribution, Metabolism and Excretion (ADME) properties of 5-Fluorouracil (5FU). A chemotherapy drug 5-Fluorouracil (5FU) decelerate the growth of cancer cells for treatment of different types of cancer like breast cancer ,colon or rectal cancer, pancreatic cancer and stomach cancer
Keywords: 5-Fluorouracil, SwissADME, drug discovery, Lipinski's rule of five
How to Cite:
[1] K. Laxmi, “SWISSADME PREDICTIONS OF PHARMACOKINETICS AND DRUG-LIKENESS PROPERTIES OF 5-FLUOROURACIL (5FU),” International Advanced Research Journal in Science, Engineering and Technology (IARJSET), DOI: 10.17148/IARJSET.2025.12655
This work is licensed under a Creative Commons Attribution 4.0 International License.